Vip 6 mg
Main Image

Vip 6 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma VIP 6 mg – Synthetic Vasoactive Intestinal Peptide for Research

✔ Synthetic 28-amino-acid neuropeptide ✔ Potent vasodilator and neurotransmitter ✔ Immune system regulator ✔ USA domestic shipping available

Dragon Pharma VIP 6 mg is a synthetic form of Vasoactive Intestinal Peptide (VIP), a 28-amino-acid human neuropeptide hormone that functions as a potent vasodilator, neurotransmitter, and immune system regulator. Produced naturally in the gastrointestinal tract, pancreas, and brain, VIP plays critical roles in smooth muscle relaxation, fluid and electrolyte secretion, and the modulation of inflammatory responses.

Each vial contains 6 mg of lyophilized VIP in a 2 mL format, requiring reconstitution with bacteriostatic water before use. This peptide has been extensively studied for its diverse biological activities, including vasodilation, neuroprotection, immunomodulation, and regulation of digestive and respiratory functions. For related research compounds, explore our peptides category and specifically Semax for complementary neuropeptide research applications.

What Makes VIP Valuable in Research?

VIP is a pleiotropic neuropeptide with a wide range of biological effects. Its ability to act as a potent vasodilator, relax smooth muscle, and modulate immune responses makes it a valuable research tool for investigating multiple physiological systems. VIP interacts with specific receptors (VPAC1 and VPAC2) that are widely distributed throughout the body, enabling its diverse functions.

Researchers value VIP for its versatility and its role in connecting nervous, endocrine, and immune systems. Its involvement in conditions ranging from inflammation and autoimmune disorders to gastrointestinal and respiratory function makes it relevant to numerous research areas. For investigators exploring immune-modulating peptides, Thymosin Alpha-1 offers complementary research avenues in immune system regulation.

Current scientific literature on VIP can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.

Key Research Applications for Dragon Pharma VIP

  • ✔ Investigation of vasodilation and vascular regulation
  • ✔ Evaluation of smooth muscle relaxation mechanisms
  • ✔ Research on immune system modulation and inflammation
  • ✔ Studies of gastrointestinal and respiratory physiology
  • ✔ Preclinical models of neuroprotection and neural function
For Research Purposes Only

VIP 6 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on gastrointestinal function, BPC 157 provides additional research avenues in digestive tissue protection.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma VIP 6 mg is a synthetic human neuropeptide. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 6 mg format allows for precise dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, VIP is typically administered via subcutaneous, intravenous, or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in vascular and smooth muscle studies</li> <li>✔ Often combined with physiological and immunological analysis</li> <li>✔ Used to investigate neuropeptide signaling pathways</li> <li>✔ Research models include inflammation, digestion, and respiratory paradigms</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Pleiotropic peptide with multiple receptor targets</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> VIP is a 28-amino-acid neuropeptide with pleiotropic biological activities. Its potent vasodilatory, neurotransmitter, and immunomodulatory functions make it a versatile tool for investigating multiple physiological systems, including cardiovascular, gastrointestinal, respiratory, and immune function.</p> </div> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Endogenous Neuropeptide
Peptide Sequence
HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH₂
Peptide Length
28 Amino-Acid Residues
Terminal Form
C-Terminal Amide (-NH₂)
Molecular Formula
C₁₄₇H₂₃₇N₄₃O₄₃S
Molecular Weight
3325.8 g/mol
CAS Number
40077-57-4
PubChem CID
16132369
Primary Receptors
VPAC1 + VPAC2
Receptor Activity
VPAC1 / VPAC2 Agonist
Peptide Family
Secretin / Glucagon Peptide Family

Chat on WhatsApp